Cover Image

The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation

Aim. To compare the change in quality of life indicators and the main clinical and instrumental parameters in patients with chronic heart failure (CHF) and functional mitral regurgitation (FMR) under the influence of sacubitril/valsartan compared with valsartan in an outpatient practice.Material and...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. S. Ryazanov (Author), E. V. Shikh (Author), O. V. Kechina (Author), M. V. Makarovskaya (Author), A. A. Kudryavtsev (Author)
Format:	Book
Published:	Столичная издательская компания, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction
by: Dima Nasrallah, et al.
Published: (2024)

Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
by: Jahanzeb Malik, et al.
Published: (2021)

Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
by: Berkay Ekici, et al.
Published: (2021)

Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF)
by: Przemysław Żelazny, et al.
Published: (2022)

Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction
by: Xiaogang Zhu, et al.
Published: (2024)

Angiotensin receptor-neprilysin inhibitor in patients with heart failure and chronic kidney disease
by: In-Jeong Cho, et al.
Published: (2021)

Angiotensin Receptor-Neprilysin Inhibitor for Chronic Kidney Disease: Strategies for Renal Protection
by: Erika Hishida, et al.
Published: (2024)

Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure
by: Kawa Dizaye, et al.
Published: (2019)

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats
by: Shao-Jung Hsu, et al.
Published: (2020)

Repair of rheumatic mitral regurgitation in children
by: Kumar A
Published: (2011)

Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure
by: Ya-Wen Lin PhD, RN, et al.
Published: (2024)

EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE
by: V. N. Larina, et al.
Published: (2016)

EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE
by: V. N. Larina, et al.
Published: (2016)

The angiotensin II receptor-neprilysin inhibitor LCZ696 attenuates the progression of proteinuria in type 2 diabetic rats
by: Asadur Rahman, et al.
Published: (2020)

Alopecia Universalis in an Elderly Chinese Man Induced by Sacubitril/Alisartan, a Novel Angiotensin Receptor-Neprilysin Inhibitor
by: Teng Y, et al.
Published: (2023)

THE ROLE OF FACTORS AFFECTING THE FORMATION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
by: M. V. Kurkina, et al.
Published: (2017)

Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches
by: A. A. Shchendrygina, et al.
Published: (2021)

Cleft posterior mitral valve leaflet: An unsuspected case of mitral regurgitation
by: Alejandro Quijada-fumero, et al.
Published: (2016)

Position of Patients with Mid-Range Ejection Fraction in the General Chronic Heart Failure Population
by: N. T. Vatutin, et al.
Published: (2021)

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
by: Artem Ovchinnikov, et al.
Published: (2022)

Comparison of the Efficacy and Safety of Sacubitril/Valsartan and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients With Reduced Ejection Fraction Combined With Moderate-to-Severe Chronic Kidney Disease
by: Zhaowei Zhang MD, et al.
Published: (2024)

The oxytocin-oxytocin receptors system - a new pathogenetic mechanism in the development of diabetic phenotype of heart failure with preserved ejection fraction in women
by: A. D. Starchenko, et al.
Published: (2024)

A rare disease causing mitral regurgitation: posterior mitral leaflet aneurysm
by: Uğur Aksu, et al.
Published: (2014)

Clinical presentation and prognosis of non valvular mitral regurgitation-A single institution experience
by: G.V. Senthilnathan, et al.
Published: (2021)

Phosphodiesterase inhibitor for heart failure with preserved ejection fraction: A systematic review and meta-analysis
by: Zhu Chen, et al.
Published: (2022)

Double orifice mitral valve: A rare cause of isolated severe congenital mitral regurgitation
by: Himanshu Pratap, et al.
Published: (2020)

Congenital left atrial appendage pseudoaneurysm, cardiomyopathy, and mitral regurgitation
by: Yaron D Barac, et al.
Published: (2020)

Left atrial fibrosis: an essential hallmark in chronic mitral regurgitation
by: Maria Concetta Pastore, et al.
Published: (2021)

Idiopathic isolated annular dilatation causing congenital mitral regurgitation
by: Lalitaditya Malik, et al.
Published: (2012)

New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024)

ALGORITHM FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION
by: E. V. Reznik, et al.
Published: (2018)

Emerging concepts in heart failure treatment and management: focus on SGLT2 inhibitors in heart failure with preserved ejection fraction
by: Andrea Beatriz De Lorenzi, et al.
Published: (2023)

Plasma digoxin levels and ejection fraction in pediatric heart failure
by: Nafrialdi Nafrialdi, et al.
Published: (2016)

New to paradigm for the treatment of heart failure with reduced ejection fraction?
by: Delfín Rodríguez Leyva
Published: (2015)

Pediatric heart failure with preserved ejection fraction, a review
by: Sophie Quennelle, et al.
Published: (2023)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024)

Severe Mitral Regurgitation in a Child With Henoch-Schönlein Purpura and Pulmonary Hemorrhage
by: Cornelius A. James MD, et al.
Published: (2017)

Delaminating Intramyocardial Hematoma in Patients with Heart Failure with Reduced Ejection Fraction: а Series of Clinical Cases
by: A. F. Safarova, et al.
Published: (2023)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023)